Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTaking Sudafed alongside Mounjaro is not flagged as a clinically significant drug interaction in current prescribing references, but there is one important practical consideration: Mounjaro slows gastric emptying, which can affect how quickly oral medicines are absorbed. A Sudafed tablet taken while your digestive system is working more slowly may be absorbed at a different rate than usual. That does not mean you cannot take a decongestant when you have a blocked nose, but it is worth understanding what is happening before you reach into the medicine cabinet. As with any medicine taken alongside a prescription treatment, the right person to ask is the clinician who prescribed Mounjaro — or a pharmacist who knows your full medication history.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Mounjaro works partly by slowing how fast your stomach empties its contents into the small intestine. This is one of the mechanisms behind the reduction in appetite that many people on the treatment notice. It is also described in detail in the NHS patient information for tirzepatide. The effect on gastric emptying is most pronounced in the early weeks of treatment and after each dose step-up, then tends to settle as your body adjusts.
Because oral medicines dissolve and are absorbed in the gut, any significant slowing of gastric emptying has the potential to affect how quickly an orally-taken drug reaches the bloodstream. In most cases the total amount absorbed is not meaningfully changed — just the timing. For a short-acting decongestant like Sudafed, a slightly delayed peak may mean the relief you expect within 30 minutes takes a little longer to arrive. That is a practical point, not a safety alarm.
The BNF entry for tirzepatide notes the gastric-emptying effect and advises clinicians to bear this in mind for any orally administered medicine where timing of absorption matters. Sudafed is not listed as a combination to avoid.
The Sudafed range sold in UK pharmacies is not a single product. Some versions contain pseudoephedrine, a sympathomimetic decongestant that works by constricting blood vessels in the nasal lining. Others contain phenylephrine. A separate Sudafed product is a non-drowsy version containing loratadine. Some combination formulations add paracetamol or ibuprofen. Knowing which one you are reaching for matters, because the cardiovascular considerations differ.
Pseudoephedrine in particular can raise blood pressure and heart rate transiently. If you are on Mounjaro partly because you have hypertension as a weight-related condition, that is worth factoring in before you buy the one behind the counter. This is not unique to Mounjaro, the same caution applies to anyone with blood pressure concerns using a sympathomimetic decongestant. A pharmacist at any UK pharmacy is well placed to advise on which Sudafed product is most appropriate for your circumstances.
For the pharmacokinetic question (the gastric-emptying effect) the same logic applies across the range: a slight delay in absorption is plausible, but no clinically significant interaction requiring avoidance has been identified in tirzepatide's prescribing documentation. If you are also exploring other aspects of combining medicines, the page on taking other GLP-1-type medicines alongside Mounjaro covers a related area.
A sensible working approach, and one that aligns with standard pharmacist advice for anyone on a medicine that slows gastric emptying, is to give a little more time for an oral decongestant to act before assuming it has not worked and taking a second dose. Stacking doses because the first seemed slow to kick in carries more risk than the interaction itself.
Keep your prescriber informed of any regular over-the-counter medicines you start while on Mounjaro. This is not bureaucratic caution, it is the foundation of safe prescribing. If your consultation is through a regulated service and you have ongoing questions about specific medicines, using the aftercare channel means a real clinician can look at the full picture.
It is also worth knowing that some people find their Mounjaro dose management affects how they feel generally during a cold or illness. There is separate guidance available if you want to understand how Mounjaro interacts with being unwell with flu.
People using tirzepatide alongside HRT or other hormonal treatments have their own set of considerations, specifically around absorption. That is covered in the page on taking Mounjaro with HRT, which draws on NHS England's guidance on this point.
Most people on Mounjaro can take a short course of a standard decongestant without difficulty. However, a conversation with a prescriber or pharmacist is genuinely worthwhile if any of these apply: you have uncontrolled blood pressure; you take regular medicines for a heart condition; you are in the early weeks of Mounjaro when gastric-emptying changes are strongest; or you are considering a multi-ingredient cold remedy where the interactions get more layered.
The broader Mounjaro overview covers the licence, clinical background and what to expect from treatment. For anyone wondering about the cost of maintaining a private prescription, the Mounjaro cost page sets out what is included in a transparent private price, and those curious about the wider commercial picture behind the treatment may find the page on Mounjaro profits a useful read.
If you are new to Mounjaro or considering starting, a free consultation with a GPhC-registered prescriber is the right starting point. Our prescribers review your medical history, current medicines and circumstances personally, not through an algorithm. Speak to our prescribers if you have questions about how any part of your current medicine routine fits with tirzepatide.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.